Oct 22, 2026 08:59AM
Oct 22, 2026 08:55AM
Sep 2, 2026 08:17AM
Aug 24, 2026 08:51AM
Aug 24, 2026 08:51AM
Sep 30, 2024 09:25AM
Sep 30, 2024 09:25AM SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
Sep 23, 2024 08:17AM
Sep 23, 2024 08:17AM
Sep 18, 2024 04:09PM
Sep 18, 2024 04:09PM
Sep 6, 2024 07:56AM
Sep 6, 2024 07:55AM
Aug 29, 2024 04:26PM Clearmind Medicine (CMND) Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
Aug 29, 2024 04:25PM
Aug 29, 2024 04:25PM
Aug 23, 2024 04:09PM
Nov 15, 2023 08:02AM
Nov 15, 2023 08:01AM
Nov 15, 2023 08:01AM
Nov 10, 2023 09:10AM SciSparc (SPRC) Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
Nov 10, 2023 09:10AM
Jun 2, 2023 09:00AM
Jun 2, 2023 09:00AM
May 2, 2023 07:27AM
May 2, 2023 07:25AM
May 2, 2023 07:25AM
Mar 6, 2023 07:45AM SciSparc (SPRC) Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome
Mar 6, 2023 07:45AM
Mar 6, 2023 07:45AM
Dec 15, 2022 09:00AM
Nov 7, 2022 08:45AM
Nov 7, 2022 08:45AM
Nov 7, 2022 08:45AM
Aug 1, 2022 09:30AM SciSparc (SPRC) Enters Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
Aug 1, 2022 09:30AM
Aug 1, 2022 09:30AM
Jul 8, 2022 08:32AM
Jul 8, 2022 08:30AM
Jul 8, 2022 08:30AM
Jun 9, 2022 08:35AM
Jun 9, 2022 08:30AM SciSparc's Board of Directors Provides Strategic Decision
Jun 9, 2022 08:30AM
Mar 30, 2022 08:30AM
Mar 30, 2022 08:30AM
Jan 18, 2022 08:02AM
Jan 6, 2022 09:00AM

335,044 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All